We will be presenting the following two papers at the 10th Annual Meeting of Nucleic Acids Therapeutics Society of Japan (NatsJ) to be held from July 1st (Tue) to 3rd (Thu), 2025 at the Kobe International House, Hall 2. If you are interested in the delivery of mRNA to immune cells, please stop by.
Pullulan polysaccharide-coated lipid nanoparticle (P-LNP) technology represents a next-generation delivery system designed to selectively target disease- and vaccine-associated myeloid cells for mRNA delivery (Symposium presentation, Paper number S5-1, Naozumi Harada)
P-LNP is a next-generation LNP technology that applies pullulan polysaccharides and enables selective delivery of mRNA to disease- and vaccine-associated myeloid cells (Poster presentation, Paper number P2-111, Shuhei Kobayashi et al.)
Conference website: https://www.natsj.jp/2025/natsj10